Michelle H Moniz1, Tammy Chang2, Matthew M Davis3, Jane Forman4, Jessica Landgraf5, Vanessa K Dalton6. 1. Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan. Electronic address: mmoniz@med.umich.edu. 2. Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan; Department of Family Medicine, University of Michigan, Ann Arbor, Michigan. 3. Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan; Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan; Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor, Michigan; Gerald R. Ford School of Public Policy, University of Michigan, Ann Arbor, Michigan. 4. Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan. 5. Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan. 6. Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan.
Abstract
OBJECTIVE: This study sought to understand state Medicaid agencies' experiences with implementing payment for long-acting reversible contraception devices inserted immediately postpartum. METHODS: We conducted semistructured telephone interviews with Medicaid representatives from 15 agencies that have specific payment methodology for immediate postpartum long-acting reversible contraception (IPLARC). Interviews investigated agency experiences with IPLARC policy implementation. Interviews were audio-recorded and professionally transcribed. We analyzed data thematically using qualitative content analysis principles. RESULTS: Described implementation experiences fell into three major categories: 1) payer preparedness regarding payment challenges, 2) health care system awareness, attitudes, and readiness to implement IPLARC policy in clinical settings, and 3) ongoing practice improvement. Within the category of payer preparedness, major emergent themes included Medicaid's need to ensure efficient claims processing, maintain appropriate reimbursement rates, and alleviate perceived provider mistrust about payment. With respect to health care systems, themes emerged around raising clinician awareness of IPLARC coverage, managing provider misconceptions about IPLARC, and addressing gaps in provider IPLARC insertion expertise. Regarding practice improvement, a salient theme emerged around the limitations of Medicaid to engage in ongoing clinical implementation and evaluation efforts. CONCLUSIONS: These findings suggest a multistakeholder implementation framework that can guide the growing number of Medicaid agencies newly implementing IPLARC policy. As more Medicaid programs remove reimbursement barriers to IPLARC, clinicians and hospital administrators have a crucial opportunity to address clinical barriers to IPLARC and ensure real-time access among beneficiaries who desire this safe and effective approach to contraception.
OBJECTIVE: This study sought to understand state Medicaid agencies' experiences with implementing payment for long-acting reversible contraception devices inserted immediately postpartum. METHODS: We conducted semistructured telephone interviews with Medicaid representatives from 15 agencies that have specific payment methodology for immediate postpartum long-acting reversible contraception (IPLARC). Interviews investigated agency experiences with IPLARC policy implementation. Interviews were audio-recorded and professionally transcribed. We analyzed data thematically using qualitative content analysis principles. RESULTS: Described implementation experiences fell into three major categories: 1) payer preparedness regarding payment challenges, 2) health care system awareness, attitudes, and readiness to implement IPLARC policy in clinical settings, and 3) ongoing practice improvement. Within the category of payer preparedness, major emergent themes included Medicaid's need to ensure efficient claims processing, maintain appropriate reimbursement rates, and alleviate perceived provider mistrust about payment. With respect to health care systems, themes emerged around raising clinician awareness of IPLARC coverage, managing provider misconceptions about IPLARC, and addressing gaps in provider IPLARC insertion expertise. Regarding practice improvement, a salient theme emerged around the limitations of Medicaid to engage in ongoing clinical implementation and evaluation efforts. CONCLUSIONS: These findings suggest a multistakeholder implementation framework that can guide the growing number of Medicaid agencies newly implementing IPLARC policy. As more Medicaid programs remove reimbursement barriers to IPLARC, clinicians and hospital administrators have a crucial opportunity to address clinical barriers to IPLARC and ensure real-time access among beneficiaries who desire this safe and effective approach to contraception.
Authors: Michel Boudreaux; Liyang Xie; Yoon Sun Choi; Dylan Habeeb Roby; Michael S Rendall Journal: Am J Public Health Date: 2020-06-18 Impact factor: 9.308
Authors: Michelle H Moniz; Vanessa K Dalton; Roger D Smith; Lauren E Owens; Zach Landis-Lewis; Alex F Peahl; Barbara Van Kainen; Margaret R Punch; Marisa K Wetmore; Kirsten Bonawitz; Giselle E Kolenic; Christine Dehlendorf; Michele Heisler Journal: Am J Obstet Gynecol Date: 2021-10-13 Impact factor: 8.661
Authors: Michelle H Moniz; Lee Roosevelt; Halley P Crissman; Emily K Kobernik; Vanessa K Dalton; Michele H Heisler; Lisa Kane Low Journal: J Midwifery Womens Health Date: 2017-09-07 Impact factor: 2.388
Authors: Charlan D Kroelinger; Isabel A Morgan; Carla L DeSisto; Cameron Estrich; Lisa F Waddell; Christine Mackie; Ellen Pliska; David A Goodman; Shanna Cox; Alisa Velonis; Kristin M Rankin Journal: J Womens Health (Larchmt) Date: 2018-11-02 Impact factor: 2.681
Authors: Ashley V Hill; Eileen Nehme; Nagla Elerian; Ella D Puga; Brandie D Taylor; David Lakey; Divya A Patel Journal: Matern Child Health J Date: 2019-12
Authors: Charlan D Kroelinger; Ekwutosi M Okoroh; Keriann Uesugi; Lisa Romero; Olivia R Sappenfield; Julia F Howland; Shanna Cox Journal: Womens Health Issues Date: 2021-10-01